๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The Efficacy of Adefovir Plus Entecavir Combination Therapy in Patients with Chronic Hepatitis B Refractory to Both Lamivudine and Adefovir

โœ Scribed by Cho, Yuri; Lee, Dong Hyeon; Chung, Kwang Hyun; Jin, Eunhyo; Lee, Jeong-Hoon; Cho, Eun Ju; Yu, Su Jong; Kim, Jin Wook; Jeong, Sook Hyang; Yoon, Jung-Hwan; Lee, Hyo-Suk; Kim, Chung Yong; Kim, Yoon Jun

Book ID
121635256
Publisher
Springer US
Year
2012
Tongue
English
Weight
264 KB
Volume
58
Category
Article
ISSN
0163-2116

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Adefovir-based combination therapy with
Adefovir-based combination therapy with entecavir or lamivudine for patients with entecavir-refractory chronic hepatitis B
โœ Soon Sun Kim; Jae Youn Cheong; Dami Lee; Myoung Hee Lee; Sun Pyo Hong; Soo-Ok Ki ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 160 KB

This study evaluated the efficacy of adefovir (ADV) plus lamivudine (LAM) or ADV add-on therapy for patients with entecavir (ETV)-refractory hepatitis B infection. Twenty-nine ETVresistant and 8 patients with suboptimal response to ETV were enrolled. Twenty-seven patients received ADV รพ LAM therapy

Efficacy of entecavir in patients with c
Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone
โœ Ju Hyun Shim; Dong Jin Suh; Kang Mo Kim; Young-Suk Lim; Han Chu Lee; Young-Hwa C ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 287 KB ๐Ÿ‘ 1 views

Entecavir (ETV) is currently recommended as a rescue therapy purely for adefovir (ADV)resistant chronic hepatitis B virus (HBV) infections. We evaluated the efficacy of ETV in patients who were resistant to lamivudine (LAM)/ADV sequential therapy and in those resistant to LAM monotherapy. Fifty LAM/